D. E. Shaw & Co., Inc. V Tv Therapeutics Inc. Transaction History

D. E. Shaw & Co., Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.53 - $2.22 $277,867 - $403,180	-181,613 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.27 - $3.44 $412,261 - $624,748	181,613 New	181,613 $414,000
Q1 2020 May 15, 2020	SELL	$1.63 - $3.75 $33,719 - $77,576	-20,687 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$1.37 - $1.97 $12,193 - $17,533	-8,900 Reduced 30.08%	20,687 $35,000
Q3 2019 Nov 14, 2019	SELL	$1.26 - $1.77 $57,850 - $81,266	-45,913 Reduced 60.81%	29,587 $46,000
Q2 2019 Aug 14, 2019	SELL	$1.29 - $1.83 $18,447 - $26,169	-14,300 Reduced 15.92%	75,500 $108,000
Q1 2019 May 15, 2019	BUY	$1.67 - $3.12 $32,565 - $60,840	19,500 Added 27.74%	89,800 $154,000
Q4 2018 Feb 14, 2019	BUY	$0.78 - $3.74 $54,834 - $262,922	70,300 New	70,300 $186,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.14B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.